Clinical experience with 0.025 percent retinoic acid solution ('Retin-A') in the topical treatment of acne.
D000152:Acne Vulgaris / Q000188:drug therapy*; D000287:Administration, Topical; D002986:Clinical Trials as Topic; D003877:Dermatitis, Contact / Q000209:etiology; D005231:Fatty Acids, Unsaturated / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols / Q000627:therapeutic use; D012996:Solutions; D013997:Time Factors; D014801:Vitamin A / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D005231:Fatty Acids, Unsaturated; D014677:Pharmaceutical Vehicles; D011409:Propylene Glycols; D012996:Solutions; D014801:Vitamin A